142nd APHA Annual Meeting and Exposition

Annual Meeting Recordings are now available for purchase

313042
Who you know: Network models of disease

142nd APHA Annual Meeting and Exposition (November 15 - November 19, 2014): http://www.apha.org/events-and-meetings/annual
Saturday, November 15, 2014 : 10:35 AM - 11:10 AM

Stephen Eubank, PhD , Network Dynamics and Simulation Science Laboratory, Virginia Bioinformatics Institute at Virginia Tech, Blacksburg, VA
Previous topics in the institute have covered compartmental models of disease that typically assume the population mixes entirely randomly. Yet intuitively, we know this isn’t true in reality. Individuals have more contact with their friends, family and co-workers than they do with random strangers. These networks of contacts can have a profound influence on the spread of disease, and the ability of public health professionals to effectively intervene to prevent disease spread. This session will discuss the use of networks to model heterogeneous mixing of populations, both socially and spatially, using the example of a small, identifiable group of individuals existing in a larger social context during a zombie outbreak.

Learning Objectives:

  1. Compare network-based models to compartmental-based models.
  2. Describe patterns of mixing between people that may give rise to different types of contact networks.
  3. Formulate their own network based on family, friends, or workplace contacts.

Learning Areas:

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am qualified to be a proposal author on the content I am responsible for because I have taken a leading role in developing computational models of infectious diseases, and am one of the PIs of the research groups in the NIH's MIDAS (Modeling Infectious Disease Agent Study) network.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.